Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma di Felipe Ades, Otto Metzger-Filho

Testo

Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications di Romualdo Barroso-Sousa, Otto Metzger-Filho

Testo

Neoadjuvant Treatment of Stage IIB/III Triple Negative Breast Cancer with Cyclophosphamide, Doxorubicin, and Cisplatin (CAP Regimen): A Single Arm, Single Center Phase II Study (GB... di Arlindo R. Ferreira, Otto Metzger-Filho, Roberta M. B. Sarmento, José Bines

Testo

Linfoma Não-Hodgkin de Alto Grau - Revisão da Literatura di Luiz Henrique de Lima Araújo, Ana Paula Ornellas de Souza Victorino, Andréia Cristina de Melo, Daniele Xavier Assad, Danilo Silva Lima, Divaldo Rodrigues de Alencar, Melba Moura Lobo Moreira, Otto Metzger Filho, Rafaela de Faria de Souza Coelho, Selem Brandão Asmar, Bruno dos Santos Vilhena Pereira, Adriana Scheliga

Testo

International survey on invasive lobular breast cancer identifies priority research questions di Steffi Oesterreich, Leigh Pate, Adrian V. Lee, Fangyuan Chen, Rachel C. Jankowitz, Rita Mukhtar, Otto Metzger, Matthew J. Sikora, Christopher I. Li, Christos Sotiriou, Osama S. Shah, Thijs Koorman, Gary Ulaner, Jorge S. Reis-Filho, Nancy M. Davidson, Karen Van Baelen, Laurie Hutcheson, Siobhan Freeney, Flora Migyanka, Claire Turner, Patrick Derksen, Todd Bear, Christine Desmedt

Testo

The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer di Michalina Janiszewska, Shayna Stein, Otto Metzger Filho, Jennifer Eng, Natalie L. Kingston, Nicholas W. Harper, Inga H. Rye, Maša Alečković, Anne Trinh, Katherine C. Murphy, Elisabetta Marangoni, Simona Cristea, Benjamin Oakes, Eric P. Winer, Ian E. Krop, Hege G. Russnes, Paul T. Spellman, Elmar Bucher, Zhi Hu, Koei Chin, Joe W. Gray, Franziska Michor, Kornelia Polyak

Testo

A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer di Adrienne G. Waks, Neelam V. Desai, Tianyu Li, Philip D. Poorvu, Ann H. Partridge, Natalie Sinclair, Laura M. Spring, Meredith Faggen, Michael Constantine, Otto Metzger, Jillian Alberti, Julia Deane, Shoshana M. Rosenberg, Elizabeth Frank, Sara M. Tolaney, Ian E. Krop, Nadine M. Tung, Nabihah Tayob, Tari A. King, Elizabeth A. Mittendorf, Eric P. Winer

Testo

Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer. di Otto Metzger-Filho, Aurélie Catteau, Stefan Michiels, Marc Buyse, Michail Ignatiadis, Kamal S Saini, Evandro de Azambuja, Virginie Fasolo, Sihem Naji, Jean Luc Canon, Paul Delrée, Michel Coibion, Pino Cusumano, Veronique Jossa, Jean Pierre Kains, Denis Larsimont, Vincent Richard, Daniel Faverly, Nathalie Cornez, Peter Vuylsteke, Brigitte Vanderschueren, Hélène Peyro-Saint-Paul, Martine Piccart, Christos Sotiriou

Testo

Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer di Jennifer L. Guerriero, Jia-Ren Lin, Ricardo G. Pastorello, Ziming Du, Yu-An Chen, Madeline G. Townsend, Kenichi Shimada, Melissa E. Hughes, Siyang Ren, Nabihah Tayob, Kelly Zheng, Shaolin Mei, Alyssa Patterson, Krishan L. Taneja, Otto Metzger, Sara M. Tolaney, Nancy U. Lin, Deborah A. Dillon, Stuart J. Schnitt, Peter K. Sorger, Elizabeth A. Mittendorf, Sandro Santagata

Testo

Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness di Otto Metzger-Filho, Katharine Collier, Sarah Asad, Peter J. Ansell, Mark Watson, Junu Bae, Mathew Cherian, Joyce O’Shaughnessy, Michael Untch, Hope S. Rugo, Jens B. Huober, Mehra Golshan, William M. Sikov, Gunter von Minckwitz, Priya Rastogi, Lang Li, Lijun Cheng, David Maag, Norman Wolmark, Carsten Denkert, W. Fraser Symmans, Charles E. Geyer, Sibylle Loibl, Daniel G. Stover

Testo

Awareness, Knowledge, and Treatment Patterns of Nonmetastatic Inflammatory Breast Cancer in Low- and Middle-Income Countries: The BRIDGES Study di Ilana Schlam, Kelly A. Hirko, Daniela Shveid, Inas Abuali, Sarah Sewaralthahab, Faina Nakhils, Aditi Hazra, Csongor Lengyel, Sara Altuna, Sadaqat Hussain, Fahmi Seid, Sara Jamil, Andrew Odhiambo, Jose Pablo Leone, Otto Metzger, Jame Abraham, Enrique Soto-Perez-de-Celis, Wendy Y. Chen, Caroline Block, Susan Schumer, Jennifer R. Bellon, Carmine Valenza, Giuseppe Curigliano, Sara M. Tolaney, Filipa Lynce, Dario Trapani

Testo